The Influence of EGFR Inactivation on the Radiation Response in High Grade Glioma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Influence of EGFR Inactivation on the Radiation Response in High Grade Glioma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 1, Pages 229
Publisher
MDPI AG
Online
2018-01-15
DOI
10.3390/ijms19010229
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma
- (2015) Francisco Azuaje et al. Cell Communication and Signaling
- Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme
- (2014) Adam M Swartz et al. Immunotherapy
- Targeted molecular therapies against epidermal growth factor receptor: Past experiences and challenges
- (2014) D. A. Reardon et al. NEURO-ONCOLOGY
- EGFR Variant Heterogeneity in Glioblastoma Resolved through Single-Nucleus Sequencing
- (2014) J. M. Francis et al. Cancer Discovery
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- The integrated landscape of driver genomic alterations in glioblastoma
- (2013) Veronique Frattini et al. NATURE GENETICS
- Disrupting the mTOR Signaling Network as a Potential Strategy for the Enhancement of Cancer Radiotherapy
- (2012) Francis J. Dumont et al. CURRENT CANCER DRUG TARGETS
- Nimotuzumab treatment of malignant gliomas
- (2012) Udo Bode et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Impact of Epidermal Growth Factor Receptor (EGFR) Cell Surface Expression Levels on Effector Mechanisms of EGFR Antibodies
- (2012) S. Derer et al. JOURNAL OF IMMUNOLOGY
- A phase I/II trial of vandetanib for patients with recurrent malignant glioma
- (2012) T. N. Kreisl et al. NEURO-ONCOLOGY
- EGFRvIII gene rearrangement is an early event in glioblastoma tumorigenesis and expression defines a hierarchy modulated by epigenetic mechanisms
- (2012) C A Del Vecchio et al. ONCOGENE
- A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
- (2011) J. J. Raizer et al. NEURO-ONCOLOGY
- Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile
- (2011) Daniel Hägerstrand et al. NEURO-ONCOLOGY
- Loco-regional treatments in first-diagnosis glioblastoma: literature review on association between Stupp protocol and Gliadel
- (2011) Andrea Salmaggi et al. NEUROLOGICAL SCIENCES
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas
- (2010) T. Ozawa et al. GENES & DEVELOPMENT
- PI3K/PTEN/Akt pathway status affects the sensitivity of high-grade glioma cell cultures to the insulin-like growth factor-1 receptor inhibitor NVP-AEW541
- (2010) Daniel Hägerstrand et al. NEURO-ONCOLOGY
- Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma
- (2009) B. Neyns et al. ANNALS OF ONCOLOGY
- A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation
- (2009) Brian Thiessen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
- (2009) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells
- (2009) Hui-Fang Li et al. Radiation Oncology
- Dehydroepiandrosterone augments sensitivity toγ-ray irradiation in human H4 neuroglioma cells through down-regulation of Akt signaling
- (2008) Tomohito Hirao et al. FREE RADICAL RESEARCH
- Growth factor receptors signaling in glioblastoma cells: therapeutic implications
- (2008) Mia Carapancea et al. JOURNAL OF NEURO-ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now